| Product NDC: | 76466-075 |
| Proprietary Name: | VAGI-CURE (REGULAR STRENGTH) |
| Non Proprietary Name: | BENZOCAINE, BENZALKONIUM CHLORIDE |
| Active Ingredient(s): | .13; 50 mg/g; mg/g & nbsp; BENZOCAINE, BENZALKONIUM CHLORIDE |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 76466-075 |
| Labeler Name: | SCI International, Inc. DBA Continental Pharmaceuticals |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part348 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20110101 |
| Package NDC: | 76466-075-07 |
| Package Description: | 21 g in 1 TUBE (76466-075-07) |
| NDC Code | 76466-075-07 |
| Proprietary Name | VAGI-CURE (REGULAR STRENGTH) |
| Package Description | 21 g in 1 TUBE (76466-075-07) |
| Product NDC | 76466-075 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | BENZOCAINE, BENZALKONIUM CHLORIDE |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20110101 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | SCI International, Inc. DBA Continental Pharmaceuticals |
| Substance Name | BENZALKONIUM CHLORIDE; BENZOCAINE |
| Strength Number | .13; 50 |
| Strength Unit | mg/g; mg/g |
| Pharmaceutical Classes |